MiECS study is new large, high quality RCT under the auspices of Minimal Invasive Extracorporeal Technologies International Society (MiECTiS), that aims to ultimately address the uncertainty about the effectiveness of MiECC in the light of the resurgence in cardiac activity by most cardiac centres worldwide.

By incorporating the lessons learned from COMICS, the new study could focus on specific perfusion-related clinical outcomes after cardiac surgery that could be potentially affected by MiECC. It will also target for higher-risk patients undergoing complex procedures that are more likely to develop complications and, thus, benefit from the advanced technology.

To access the LIVE registry please click here